Literature DB >> 3826491

Cryptosporidiosis in Haitian children.

J W Pape, E Levine, M E Beaulieu, F Marshall, R Verdier, W D Johnson.   

Abstract

We used a modified acid-fast stain to detect Cryptosporidium oocysts in unconcentrated stools from 824 Haitian children less than 2 years of age with acute diarrhea. Oocysts were identified in stools from 17.5% of 291 children seen at a rural dispensary and in 16.3% of stools from 533 children in an urban hospital. Children with cryptosporidiosis were identified throughout a 22-month period from October 1982 to July 1984, without seasonal predilection. Cryptosporidiosis was twice as common in infants greater than 6 months of age than in younger infants. Cryptosporidium oocysts were rarely found in stools of infants receiving only breast milk. The clinical presentation of children with cryptosporidiosis was similar to other patients with diarrhea who did not have cryptosporidiosis. No asymptomatic Cryptosporidium infections were detected among 71 family members of 31 children with cryptosporidiosis. Three of the 71 family members less than 3 years of age were found to have diarrhea and Cryptosporidium oocysts. In follow-up studies of 31 patients, oocysts persisted in stools for a mean of 14 days (range 5-31 days). Duration of oocyst excretion was directly correlated with duration of diarrhea. These findings suggest that Cryptosporidium is an important cause of acute self-limited diarrheal illness to Haitian children.

Entities:  

Mesh:

Year:  1987        PMID: 3826491     DOI: 10.4269/ajtmh.1987.36.333

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  9 in total

Review 1.  Epidemiological aspects of human cryptosporidiosis.

Authors:  D P Casemore
Journal:  Epidemiol Infect       Date:  1990-02       Impact factor: 2.451

2.  Importance of cholera and other etiologies of acute diarrhea in post-earthquake Port-au-Prince, Haiti.

Authors:  Macarthur Charles; Glavdia G Delva; Jethro Boutin; Karine Severe; Mireille Peck; Marie Marcelle Mabou; Peter F Wright; Jean W Pape
Journal:  Am J Trop Med Hyg       Date:  2014-01-20       Impact factor: 2.345

3.  Cryptosporidium parvum (Apicomplexa: Cryptosporidiidae) oocyst and sporozoite antigens recognized by bovine colostral antibodies.

Authors:  M Tilley; R Fayer; A Guidry; S J Upton; B L Blagburn
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

4.  Immunotherapeutic efficacy of bovine colostral immunoglobulins from a hyperimmunized cow against cryptosporidiosis in neonatal mice.

Authors:  R Fayer; A Guidry; B L Blagburn
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

5.  Cloning and characterization of the acidic ribosomal protein P2 of Cryptosporidium parvum, a new 17-kilodalton antigen.

Authors:  Jeffrey W Priest; James P Kwon; Joel M Montgomery; Caryn Bern; Delynn M Moss; Amanda R Freeman; Cara C Jones; Michael J Arrowood; Kimberly Y Won; Patrick J Lammie; Robert H Gilman; Jan R Mead
Journal:  Clin Vaccine Immunol       Date:  2010-04-21

Review 6.  Cryptosporidiosis.

Authors:  W L Current; L S Garcia
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

7.  Seasonality of cryptosporidiosis: A meta-analysis approach.

Authors:  Jyotsna S Jagai; Denise A Castronovo; Jim Monchak; Elena N Naumova
Journal:  Environ Res       Date:  2009-03-27       Impact factor: 6.498

8.  Evaluation of an antigen capture enzyme-linked immunosorbent assay for detection of Cryptosporidium oocysts.

Authors:  R D Newman; K L Jaeger; T Wuhib; A A Lima; R L Guerrant; C L Sears
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

9.  Cryptosporidiosis in Haiti: surprisingly low level of species diversity revealed by molecular characterization of Cryptosporidium oocysts from surface water and groundwater.

Authors:  Céline Damiani; Ketty Balthazard-Accou; Elmyre Clervil; Aïssata Diallo; Cécilia Da Costa; Evens Emmanuel; Anne Totet; Patrice Agnamey
Journal:  Parasite       Date:  2013-11-20       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.